These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 37282822)
1. Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF-κB pathway in canine mammary carcinoma cells. Wang J; Li M; Li M Vet Comp Oncol; 2023 Sep; 21(3):520-532. PubMed ID: 37282822 [TBL] [Abstract][Full Text] [Related]
2. Oncolytic effect of Newcastle disease virus is attributed to interferon regulation in canine mammary cancer cell lines. Santos MR; Xavier PLP; Pires PRL; Rochetti AL; Rosim DF; Scagion GP; de Campos Zuccari DAP; Munir M; Ferreira HL; Fukumasu H Vet Comp Oncol; 2021 Sep; 19(3):593-601. PubMed ID: 33871162 [TBL] [Abstract][Full Text] [Related]
3. Fusion protein and hemagglutinin of canine distemper virus co-induce apoptosis in canine mammary tumor cells. Gu C; Su J; Wang J; Xie Q; Wu J; Xiao J; Liu W J Cancer Res Clin Oncol; 2023 Sep; 149(12):9903-9918. PubMed ID: 37249647 [TBL] [Abstract][Full Text] [Related]
5. Oncolytic activity of canine distemper virus in canine mammary tubular adenocarcinoma cells. Li P; Wang J; Chen G; Zhang X; Lin D; Zhou Y; Yu Y; Liu W; Zhang D Vet Comp Oncol; 2019 Jun; 17(2):174-183. PubMed ID: 30756476 [TBL] [Abstract][Full Text] [Related]
6. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells. Jiang K; Song C; Kong L; Hu L; Lin G; Ye T; Yao G; Wang Y; Chen H; Cheng W; Barr MP; Liu Q; Zhang G; Ding C; Meng S BMC Cancer; 2018 Jul; 18(1):746. PubMed ID: 30021550 [TBL] [Abstract][Full Text] [Related]
7. Type I interferon-sensitive recombinant newcastle disease virus for oncolytic virotherapy. Elankumaran S; Chavan V; Qiao D; Shobana R; Moorkanat G; Biswas M; Samal SK J Virol; 2010 Apr; 84(8):3835-44. PubMed ID: 20147405 [TBL] [Abstract][Full Text] [Related]
8. Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death. Elankumaran S; Rockemann D; Samal SK J Virol; 2006 Aug; 80(15):7522-34. PubMed ID: 16840332 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Apoptosis Induction by Newcastle Disease Virus LaSota Strain in Human Breast Carcinoma Cells. Kalantari A; Farashi Bonab S; Keyvanfar H; Mortazavi P Arch Razi Inst; 2020 Oct; 75(3):367-376. PubMed ID: 33025777 [TBL] [Abstract][Full Text] [Related]
10. Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway. Ch'ng WC; Abd-Aziz N; Ong MH; Stanbridge EJ; Shafee N Cell Oncol (Dordr); 2015 Aug; 38(4):279-88. PubMed ID: 25930675 [TBL] [Abstract][Full Text] [Related]
11. The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice model. He J; An Y; Qi J; Cui L; Yang K; Liu M; Qu B; Yan S; Yin J; Jing X; Dong H; Yu Q; Li D; Wu Y J Med Virol; 2021 Jun; 93(6):3890-3898. PubMed ID: 32779745 [TBL] [Abstract][Full Text] [Related]
12. Oncolytic Newcastle disease virus carrying the IL24 gene exerts antitumor effects by inhibiting tumor growth and vascular sprouting. Wu Q; Jin Y; Li S; Guo X; Sun W; Liu J; Li Q; Niu D; Zou Y; Du X; Li Y; Zhao T; Li Z; Li X; Ren G Int Immunopharmacol; 2024 Jul; 136():112305. PubMed ID: 38823178 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the in vitro and in vivo effect of liposomal doxorubicin along with oncolytic Newcastle disease virus on 4T1 cell line: Animal preclinical research. Faranoush P; Jahandideh A; Nekouian R; Mortazavi P Vet Med Sci; 2023 May; 9(3):1426-1437. PubMed ID: 36920334 [TBL] [Abstract][Full Text] [Related]
14. Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma. Sánchez D; Pelayo R; Medina LA; Vadillo E; Sánchez R; Núñez L; Cesarman-Maus G; Sarmiento-Silva RE Viruses; 2015 Dec; 8(1):. PubMed ID: 26703717 [TBL] [Abstract][Full Text] [Related]
15. Combined therapy of oncolytic Newcastle disease virus and rhizomes extract of Rheum ribes enhances cancer virotherapy in vitro and in vivo. Al-Shammari AM; Jalill RDA; Hussein MF Mol Biol Rep; 2020 Mar; 47(3):1691-1702. PubMed ID: 31970625 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells. Jiang K; Li Y; Zhu Q; Xu J; Wang Y; Deng W; Liu Q; Zhang G; Meng S BMC Cancer; 2014 Jul; 14():551. PubMed ID: 25078870 [TBL] [Abstract][Full Text] [Related]
17. Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells. Wang X; Shao X; Gu L; Jiang K; Wang S; Chen J; Fang J; Guo X; Yuan M; Shi J; Ding C; Meng S; Xu Q J Cell Mol Med; 2020 Apr; 24(7):4286-4297. PubMed ID: 32100392 [TBL] [Abstract][Full Text] [Related]
18. Intratumoral Virotherapy with Wild-Type Newcastle Disease Virus in Carcinoma Krebs-2 Cancer Model. Yurchenko KS; Glushchenko AV; Gulyaeva MA; Bi Y; Chen J; Shi W; Adamenko LS; Shestopalov AM Viruses; 2021 Mar; 13(4):. PubMed ID: 33806229 [TBL] [Abstract][Full Text] [Related]
19. Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma. Vijayakumar G; Palese P; Goff PH EBioMedicine; 2019 Nov; 49():96-105. PubMed ID: 31676387 [TBL] [Abstract][Full Text] [Related]
20. Persistent Newcastle disease virus infection in bladder cancer cells is associated with putative pro-survival and anti-viral transcriptomic changes. Chan LC; Kalyanasundram J; Leong SW; Masarudin MJ; Veerakumarasivam A; Yusoff K; Chan SC; Chia SL BMC Cancer; 2021 May; 21(1):625. PubMed ID: 34044804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]